Cargando…
Macrolide Resistance in MORDOR I: A Cluster-Randomized Trial in Niger
Autores principales: | Doan, Thuy, Arzika, Ahmed M, Hinterwirth, Armin, Maliki, Ramatou, Zhong, Lina, Cummings, Susie, Sarkar, Samarpita, Chen, Cindi, Porco, Travis C, Keenan, Jeremy D, Lietman, Thomas M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Massachusetts Medical Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518950/ https://www.ncbi.nlm.nih.gov/pubmed/31167060 http://dx.doi.org/10.1056/NEJMc1901535 |
Ejemplares similares
-
Selection of Macrolide and Non-Macrolide Resistance with Mass Azithromycin
Distribution: A Community-Randomized Trial
por: Doan, Thuy, et al.
Publicado: (2020) -
Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger
por: Hazel, Ashley, et al.
Publicado: (2023) -
Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger
por: O’Brien, Kieran S., et al.
Publicado: (2020) -
Post-antibiotic Ocular Surface Microbiome in Children: A Cluster-Randomized Trial
por: Doan, Thuy, et al.
Publicado: (2020) -
MORDOR II: Persistence of Benefit of Azithromycin for Childhood
Mortality
por: Keenan, Jeremy D., et al.
Publicado: (2019)